Clinical Trials Logo

Filter by:
NCT ID: NCT00706082 Terminated - Clinical trials for Pulmonary Hypertension

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

DETECT
Start date: October 2008
Phase: N/A
Study type: Observational

A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension

NCT ID: NCT00704301 Terminated - Delirium Clinical Trials

Rivastigmine for Intensive Care Unit (ICU) Delirium

Start date: November 2008
Phase: Phase 4
Study type: Interventional

Delirium in Intensive Care (IC) patients is a frequent disorder. The aim of this study is to investigate whether treatment of delirium in the ICU with rivastigmine added to haloperidol shortens the duration of delirium in comparison to placebo added to the treatment with haloperidol.

NCT ID: NCT00703157 Terminated - Atrial Fibrillation Clinical Trials

Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) Patients

SCALAF
Start date: November 2007
Phase: N/A
Study type: Interventional

Prospective randomized interventional trial comparing the efficacy of circumferential pulmonary vein ostia ablation using surgical versus catheter techniques in the treatment of paroxysmal atrial fibrillation. Success rate determined by REVEAL-XT (AF implantable monitoring device).

NCT ID: NCT00700739 Terminated - Clinical trials for Cervical Degenerative Disc Disease

Study to Investigate the Performance of Cervical Arthroplasty for the Treatment of Cervical Degenerative Disc Disease

Start date: May 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate the performance of the Discover cervical Artificial disc in the treatment of degenerative disc disease in one level of the cervical spine.

NCT ID: NCT00696631 Terminated - Clinical trials for Congestive Heart Failure

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

ANDROMEDA
Start date: June 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy, tolerability and safety of dronedarone versus placebo in patients with symptomatic congestive heart failure (CHF) and left ventricular dysfunction (LVD) when added to evidence based treatments for CHF.

NCT ID: NCT00687986 Terminated - Lung Cancer Clinical Trials

Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer

ROSEL
Start date: October 2008
Phase: Phase 3
Study type: Interventional

The standard treatment for an early stage I lung cancer is surgery. However, surgery can be associated with complications and long-term impairment of the quality of life of patients. Stereotactic radiotherapy (SRT) is a outpatient technique which allows for local control rates that are comparable to those achieved using surgery. In this study, patients with stage IA non-small cell lung cancer will be randomized to either surgery or SRT in order to study the local and regional tumor control, quality of life and treatment costs at 2- and 5-years.

NCT ID: NCT00687609 Terminated - Clinical trials for Attention Deficit Hyperactivity Disorder

Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

PEACE
Start date: September 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether atomoxetine is effective in reducing ADHD (Attention Deficit/Hyperactivity Disorder) symptoms in adolescents with ADHD and comorbid cannabis abuse.

NCT ID: NCT00684216 Terminated - Breast Cancer Clinical Trials

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Interventional

This trial studies the effects on quality of life and on time to second progression of the sequence endocrine therapy-capecitabine versus the sequence capecitabine-endocrine treatment. It is anticipated that the time on study (which is the time between randomization and the discontinuation of the second treatment in the sequence) will be similar for both arms of the study. The quality of life during this period, however, could be better in the patient group receiving the most effective first agent in the sequence. If this proves to be true, the conventional wisdom that endocrine therapy should be continued until no further endocrine options remain, must be abandoned.

NCT ID: NCT00683696 Terminated - Heart Failure Clinical Trials

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

EchoCRT
Start date: August 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic dysfunction, already receiving optimized HF medication, with a narrow QRS width (< 130 ms) and echocardiographic evidence of ventricular dyssynchrony.

NCT ID: NCT00679484 Terminated - Clinical trials for Chronic Heart Failure

Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24

OLMEBNP
Start date: June 2008
Phase: Phase 3
Study type: Interventional

This study will compare olmesartan medoxomil to candesartan cilexetil in reducing BNP, a prognostic biomarker of heart failure, at week 24